Skip to content

Immunoassay Control Level 3 94103

by Cliniqa Corporation

Immunoassay Control Level 3 94103 is a Class I device made by Cliniqa Corporation, cleared under FDA 510(k) K083554 on 21 Apr 2009 and listed in FDA GUDID since 22 Aug 2018 (UDI-DI 00817238010424), active as of 8 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 8 Nov 2026

Documents

510(k) K083554

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 8 Nov 2026.

Regulatory status

as of registry sync 8 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00817238010424 UDI-DI Date22 Aug 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK083554 Date21 Apr 2009DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K083554 decided 21 Apr 2009 Active
  • FDA GUDID UDI-DI 00817238010424 listed 22 Aug 2018 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K083554
  2. Listed FDA GUDID 00817238010424

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
Immunoassay Control Level 3
Generic name
Multiple-type clinical chemistry analyte profile IVD, control
Model / reference
94103
Primary DI / UDI-DI
00817238010424
510(k) Number
FDA product code
JJY
GMDN term
Multiple-type clinical chemistry analyte profile IVD, control
Device class
Class I
Regulation number
862.1660
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Multiple-type clinical chemistry analyte profile IVD, control.

Other devices from Cliniqa Corporation

See all devices from Cliniqa Corporation →

Properties

  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)